Photo from Zhen Su/LinkedIn
Jan 19, 2024, 13:42
Zhen Su: Another Sea Change of oncology care led by cancer immunotherapy
Zhen Su, Physician Scientist, Entrepreneur and CEO at Marengo Therapeutics, shared a post on LinkedIn:
“Another Sea Change of oncology care led by cancer immunotherapy: 5 new IO therapeutics have been approved for the over the past 2 years and brought significant clinical benefits for patients. The rapid evolution of the MM treatment landscape is highlighted in this nice review by Ajay K. Nooka, MD, MPH.”
Source: Zhen Su/LinkedIn
-
ESMO 2024 Congress
September 13-17, 2024
-
ASCO Annual Meeting
May 30 - June 4, 2024
-
Yvonne Award 2024
May 31, 2024
-
OncoThon 2024, Online
Feb. 15, 2024
-
Global Summit on War & Cancer 2023, Online
Dec. 14-16, 2023
Nov 14, 2024, 09:31
Nov 14, 2024, 09:26
Nov 14, 2024, 09:21
Nov 14, 2024, 09:15
Nov 14, 2024, 00:19